Charles River, Parexel, PPD: PharmAsia News CRO Earnings Roundup
This article was originally published in PharmAsia News
Executive Summary
The largest contract research organizations have begun to spread their reach into emerging markets to keep pace with their big pharma customers
You may also be interested in...
Korean Government Shifts Attention To CRO Sector In Steady Drive To Build Up Biotech Infrastructure, Biosimilars
SEOUL - After realizing that it was a late comer, the Korean government is now moving to strengthen its local CRO industry to support a clinical trial infrastructure that is bursting at the seams as MNCs flock to Korea to conduct early-stage trials
Korean Government Shifts Attention To CRO Sector In Steady Drive To Build Up Biotech Infrastructure, Biosimilars
SEOUL - After realizing that it was a late comer, the Korean government is now moving to strengthen its local CRO industry to support a clinical trial infrastructure that is bursting at the seams as MNCs flock to Korea to conduct early-stage trials
J&J, GSK, AstraZeneca's Emerging Markets Roundup: PharmAsia News Earnings Call Roundup
Quarterly earnings calls seem lacking these days unless a company references its plans for emerging markets. PharmAsia News combs through quarterly earnings reports to spot developing trends in emerging market strategies.